{"abstract":"The Food and Drug Administration (FDA) is announcing the withdrawal of certain advance notice of proposed rulemakings (ANPRMs), proposed rules, and other proposed actions that published in the Federal Register more than 5 years ago. These proposals are no longer considered viable candidates for final action at this time. FDA is taking this action to reduce its regulatory backlog and focus its resources on current public health issues. The FDA's actions are part of an overall regulatory reform strategy initiated by Health and Human Services (HHS) Secretary Tommy G. Thompson.","action":"Withdrawal of proposed rules.","agencies":[{"raw_name":"DEPARTMENT OF HEALTH AND HUMAN SERVICES","name":"Health and Human Services Department","id":221,"url":"https://www.federalregister.gov/agencies/health-and-human-services-department","json_url":"https://www.federalregister.gov/api/v1/agencies/221","parent_id":null,"slug":"health-and-human-services-department"},{"raw_name":"Food and Drug Administration","name":"Food and Drug Administration","id":199,"url":"https://www.federalregister.gov/agencies/food-and-drug-administration","json_url":"https://www.federalregister.gov/api/v1/agencies/199","parent_id":221,"slug":"food-and-drug-administration"}],"body_html_url":"https://www.federalregister.gov/documents/full_text/html/2004/11/26/04-26234.html","cfr_references":[{"chapter":1,"citation_url":null,"part":null,"title":21}],"citation":"69 FR 68831","comment_url":null,"comments_close_on":null,"correction_of":null,"corrections":[],"dates":"The proposed rules are withdrawn as of November 26, 2004.","disposition_notes":null,"docket_ids":["Docket No. 2002N-0434"],"dockets":[{"supporting_documents":[{"title":"Envelope re: Comment from the Honorable Senator Hubert H. Humphrey","document_id":"FDA-1977-N-0002-1560"},{"title":"Envelope re: Comment from The National Grange","document_id":"FDA-1977-N-0002-0947"},{"title":"Envelope re: Comment from Honorable Guy Vander Jagt, House of Representatives","document_id":"FDA-1977-N-0002-0931"},{"title":"Envelope re: Comment from Department of Agriculture of Canada","document_id":"FDA-1977-N-0002-0913"},{"title":"Envelope re: Comment from Honorable Gillespie V. Montgomery, House of Representatives","document_id":"FDA-1977-N-0002-0907"},{"title":"Envelope re: Comment from Honorable Thomas S. Foley, House of Representatives","document_id":"FDA-1977-N-0002-0888"},{"title":"Envelope re: Comment from Atlantic County Board of Agriculture","document_id":"FDA-1977-N-0002-0879"},{"title":"Envelope re: Comment from Fulton County (Illinois) Farm Bureau","document_id":"FDA-1977-N-0002-0869"},{"title":"Envelope re: Comment from Honorable Dale Bumpers, United States Senate","document_id":"FDA-1977-N-0002-0860"},{"title":"Envelope re: Comment from United States Department of Justice","document_id":"FDA-1977-N-0002-0840"}],"agency_name":"FDA","documents":[{"comment_count":2172,"comment_start_date":"2004-11-25","updated_at":"2025-01-07T11:57:08.476-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-1977-N-0002-0948","allow_late_comments":false,"id":"FDA-1977-N-0002-0948","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":108,"id":"FDA-1977-N-0002","title":"Penicillin & Tetracycline & All Combinations - CLOSED"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2004-11-25","updated_at":"2025-01-07T11:57:09.213-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-1977-N-0026-0008","allow_late_comments":false,"id":"FDA-1977-N-0026-0008","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-1977-N-0026","title":"Gelatin; GRAS Status as Direct Human Food Ingredient"},{"supporting_documents":[],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2004-11-25","updated_at":"2025-01-07T11:57:07.720-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-1979-P-0027-0003","allow_late_comments":false,"id":"FDA-1979-P-0027-0003","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":0,"id":"FDA-1979-P-0027","title":"Exempt Homoeopathic Drug Products from G. M. P. Regulations-CLOSED"},{"supporting_documents":[{"title":"Background Material","document_id":"FDA-1982-P-0018-0379"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0366"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0361"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0349"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0344"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0337"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0330"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0323"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0298"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0296"}],"agency_name":"FDA","documents":[{"comment_count":0,"comment_start_date":"2009-12-02","updated_at":"2025-01-07T11:57:08.478-05:00","comment_url":"https://www.regulations.gov/commenton/FDA-1982-P-0018-0400","allow_late_comments":false,"id":"FDA-1982-P-0018-0400","comment_end_date":null,"regulations_dot_gov_open_for_comment":false}],"supporting_documents_count":386,"id":"FDA-1982-P-0018","title":"Reclassify Electroconvulsive Therapy (ECT) Section 513(E)-CLOSED"}],"document_number":"04-26234","effective_on":null,"end_page":68838,"executive_order_notes":null,"executive_order_number":null,"explanation":null,"full_text_xml_url":"https://www.federalregister.gov/documents/full_text/xml/2004/11/26/04-26234.xml","html_url":"https://www.federalregister.gov/documents/2004/11/26/04-26234/withdrawal-of-certain-proposed-rules-and-other-proposed-actions","images":{},"images_metadata":{},"json_url":"https://www.federalregister.gov/api/v1/documents/04-26234?publication_date=2004-11-26","mods_url":"https://www.govinfo.gov/metadata/granule/FR-2004-11-26/04-26234/mods.xml","not_received_for_publication":null,"page_length":8,"page_views":{"count":1147,"last_updated":"2026-04-04 18:15:03 -0400"},"pdf_url":"https://www.govinfo.gov/content/pkg/FR-2004-11-26/pdf/04-26234.pdf","presidential_document_number":null,"proclamation_number":null,"public_inspection_pdf_url":null,"publication_date":"2004-11-26","raw_text_url":"https://www.federalregister.gov/documents/full_text/text/2004/11/26/04-26234.txt","regulation_id_number_info":{},"regulation_id_numbers":[],"regulations_dot_gov_info":{"supporting_documents":[{"title":"Background Material","document_id":"FDA-1982-P-0018-0379"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0366"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0361"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0349"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0344"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0337"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0330"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0323"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0298"},{"title":"Background Material","document_id":"FDA-1982-P-0018-0296"}],"comments_count":0,"agency_id":"FDA","comments_url":"https://www.regulations.gov/docketBrowser?rpp=50&so=DESC&sb=postedDate&po=0&dct=PS&D=FDA-1982-P-0018","supporting_documents_count":386,"docket_id":"FDA-1982-P-0018","document_id":"FDA-1982-P-0018-0400","regulation_id_number":null,"title":"Reclassify Electroconvulsive Therapy (ECT) Section 513(E)-CLOSED","checked_regulationsdotgov_at":"2025-01-08T16:00:13Z"},"regulations_dot_gov_url":null,"significant":null,"signing_date":null,"start_page":68831,"subtype":null,"title":"Withdrawal of Certain Proposed Rules and Other Proposed Actions","toc_doc":"Proposed rules and actions published in Federal Register over 5 years ago; withdrawn","toc_subject":null,"topics":[],"type":"Proposed Rule","volume":69}